WHAT IS CANCELL?
From The Cancer Chronicles #12
[THIS WAS JUST BEFORE THE FDA BROUGHT CANCELL'S DEVELOPERS TO COURT AND BANNED ITS INTERSTATE SHIPMENT, DESPITE THE FACT THAT IT WAS BEING GIVEN AWAY.--ED.]
(Original editor's note: We have received numerous requests for information on Cancell. The reader should be warned that there are NO published scientific articles supporting the use of this substance. The information below is given purely for educational purposes and in no way constitutes an endorsement of this product.)
Cancell (Entelev) is a nontoxic treatment for cancer developed in the 1930s by a man named Jim Sheridan. Sheridan was an analytical chemist for the Dow Chemical Company. There is a great deal of mystery around Cancell. The idea for this drug came to Sheridan in a dream on the afternoon of September 6, 1936. He saw a multilayered rainbow made up of the various respiratory enzymes of the oxidation-reduction (`redox') system. The dream suggested to the young chemist the cure for cancer. In Sheridan's view, the cancer cell exists at a "critical point" between a truly primitive cell (like yeast) and a normal human cell. The goal of Cancell was to push the cancer cell into the primitive state.
"Cancell tries to take away the last vestiges of normality" from cancer cells, Sheridan said, "so they are no longer on the boundary line." He added, "Once the cancer cell is definitely into the primitive stage, the body deals with it as the body does any other foreign object. It gets rid of it."
All descriptions of Cancell's ingredients and method of manufacture seem incomplete. Sheridan has said that Cancell contains a chemical that can inhibit respiration, similar to the chemical that turns cranberries red.Sheridan claims that by 1942 he was already getting between 70 and 80 percent antitumor responses in mice. In 1953, just as human clinical tests were about to begin, Sheridan says they were blocked by representatives of the American Cancer Society.Around this time, Sheridan began giving Cancell away to patients who asked for it. This is still true.
In 1982, Sheridan received IND No. 20,258 from the FDA to test Cancell in people. It was then put on "clinical hold," a kind of bureaucratic limbo, by the agency. In 1986, FDA requested a study on the "minimum lethal dose." But Sheridan says the laboratory he chose to do the tests was scared off by the FDA.
In the 1980s, Sheridan met foundry owner Ed Sopcak who took up where he left off, giving 20,000 bottles of Cancell away, even paying for the postage. Sopcak has said patients should go off all other medications before taking Cancell or at least not to take megadoses of vitamins C and E while on this medication. Clinical results can take up to 3 months. Cancell "does not actually kill the cancer cell in the usual meaning of the word kill," Sheridan concludes. It is "effectively `asking' the body to cure itself."